See All Slides - tctmd.com

Slides

Presentation TCT 2013

CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI

Presenter: David Erlinge

October 30, 2013

Presentation TCT 2013

Vulnerable Plaque Diagnosis by OCT (with Case Vignettes)

Presenter: Ik-Kyung Jang

October 30, 2013

Presentation TCT 2013

Managing the Parade of New Renal Denervation Technology: Are the Clinical Results Generalizable or Device Specific?

Presenter: Robert Whitbourn

October 30, 2013

Presentation TCT 2013

Case #9: We Can Do a Fine Job With the Balloon Before and After Stent Implantation!

Presenter: Shao Liang Chen

October 30, 2013

Presentation TCT 2013

Introducing the Case(2)

Presenter: Ping-Han Lo

October 30, 2013

Presentation TCT 2013

FFR Clinical Trials: Review and Update

Presenter: William Fearon

October 30, 2013

Presentation TCT 2013

Atrial Septal Closure Devices: Choosing the Ideal Candidate for Transcatheter Closure

Presenter: Rebecca Hahn

October 30, 2013

Presentation TCT 2013

What Really Matters: Integrating Hard Endpoints (eg, Death, MI), Quality-of-Life Metrics, and Patient Preferences

Presenter: John Spertus

October 30, 2013

Presentation TCT 2013

Introducing the Case

Presenter: Wen-Lieng Lee

October 30, 2013

Presentation TCT 2013

Early Human Clinical Studies in the US: Requirements, Challenges and Opportunities

Presenter: Andrew Farb

October 30, 2013

Advertisement

Slides

CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI

Vulnerable Plaque Diagnosis by OCT (with Case Vignettes)

Managing the Parade of New Renal Denervation Technology: Are the Clinical Results Generalizable or Device Specific?

Case #9: We Can Do a Fine Job With the Balloon Before and After Stent Implantation!

Introducing the Case(2)

FFR Clinical Trials: Review and Update

Atrial Septal Closure Devices: Choosing the Ideal Candidate for Transcatheter Closure

What Really Matters: Integrating Hard Endpoints (eg, Death, MI), Quality-of-Life Metrics, and Patient Preferences

Introducing the Case

Early Human Clinical Studies in the US: Requirements, Challenges and Opportunities

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content